Impact of Drug-Gene-Interaction, Drug-Drug-Interaction, and Drug-Drug-Gene-Interaction on (es)Citalopram Therapy: The PharmLines Initiative
- Supplementary File 1:
RAR-Document (RAR, 110 KiB)
Bahar, M.A.; Lanting, P.; Bos, J.H.J.; Sijmons, R.H.; Hak, E.; Wilffert, B. Impact of Drug-Gene-Interaction, Drug-Drug-Interaction, and Drug-Drug-Gene-Interaction on (es)Citalopram Therapy: The PharmLines Initiative. J. Pers. Med. 2020, 10, 256. https://doi.org/10.3390/jpm10040256
Bahar MA, Lanting P, Bos JHJ, Sijmons RH, Hak E, Wilffert B. Impact of Drug-Gene-Interaction, Drug-Drug-Interaction, and Drug-Drug-Gene-Interaction on (es)Citalopram Therapy: The PharmLines Initiative. Journal of Personalized Medicine. 2020; 10(4):256. https://doi.org/10.3390/jpm10040256
Chicago/Turabian StyleBahar, Muh. A., Pauline Lanting, Jens H.J. Bos, Rolf H. Sijmons, Eelko Hak, and Bob Wilffert. 2020. "Impact of Drug-Gene-Interaction, Drug-Drug-Interaction, and Drug-Drug-Gene-Interaction on (es)Citalopram Therapy: The PharmLines Initiative" Journal of Personalized Medicine 10, no. 4: 256. https://doi.org/10.3390/jpm10040256